Liberia documents

Annual progress reports

All eligible countries are invited to submit proposals for Gavi support. 

Annual progress report Liberia 2014

Annual progress report Liberia 2013

Annual progress report Liberia 2012

Annual progress report Liberia 2011

Annual progress report Liberia 2010

Annual progress report Liberia 2009

Annual progress report Liberia 2008

Annual progress report Liberia 2007

Annual progress report Liberia 2006

Annual progress report Liberia 2004

Annual progress report Liberia 2005

Annual progress report Liberia 2003

Annual progress report Liberia 2002

Annual progress report Liberia 2001

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Proposal for NVS-YF diagnostics 2020: Liberia

Date of Gavi approval: 18 April 2020

Decision Letter Liberia IPV 2019

Date of Gavi approval: 18 September 2019

Decision Letter NVS Liberia 2017

Date of Gavi approval: 18 September 2019

Decision Letter NVS Liberia 2014(2)

Date of Gavi approval: 18 September 2019

Decision letter HSS Liberia 2012

Date of Gavi approval: 18 September 2019

Proposal for NVS Typhoid conjugate vaccine (2020): Liberia

Date of Gavi approval: 27 August 2019

Proposal for NVS - HPV routine and measles 1+2 routine support 2018 - Liberia

Date of Gavi approval: 19 November 2018

Proposal for NVS - measles follow-up campaign 2017 : Liberia

Date of Gavi approval: 20 July 2017

Proposal for PSR (HSS & CCEOP) Support 2017: Liberia

Date of Gavi approval: 22 June 2017

Proposal for NVS – IPV support

Date of Gavi approval: 30 June 2014

Proposal for NVS - Rota support: Liberia

Date of Gavi approval: 04 March 2014

Proposal for HPV Demo support: Liberia

Date of Gavi approval: 31 January 2014

Proposal for NVS - PCV support: Liberia

Date of Gavi approval: 15 February 2013

Proposal for HSS support: Liberia (2012)

Date of Gavi approval: 12 April 2012

Proposal for HSS support: Liberia

Date of Gavi approval: 12 May 2007

Proposal for ISS support: Liberia

Date of Gavi approval: 01 March 2007

Proposal for INS support: Liberia

Date of Gavi approval: 01 November 2005

Proposal for NVS - YF support: Liberia

Date of Gavi approval: 01 June 2001

Proposal for ISS support: Liberia (2000)

Date of Gavi approval: 01 November 2000

Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

Comprehensive Multi-Year Plan Liberia 2016-2020

cMYPs Liberia 2006-2010

Country co-financing information sheet

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

Co-financing information sheet Liberia

Data quality audit

The DQA has been developed by WHO to help evaluate the quality of countries' health information systems and to verify the accuracy of reported data. Read more. 

DQAs/SFPs Liberia

Decision Letters and Partnerships Agreement

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

Decision Letter M Liberia 2021

Decision Letter YF Liberia 2021

Decision Letter RV Liberia 2021

Decision Letter PENTA Liberia 2021

Decision Letter PCV Liberia 2021

Decision Letter IPV Liberia 2021

Decision Letter M Liberia 2020

Decision Letter RV Liberia 2020

Decision Letter PENTA Liberia 2020

Decision Letter PCV Liberia 2020

Decision Letter IPV Liberia 2020

Decision Letter HPV Liberia 2020

Decision Letter YF Liberia 2020

Decision Letter HSS Liberia 2020

Decision Letter M Liberia 2019

Decision Letter ISD Liberia 2019

Decision Letter IPV Liberia 2019

Decision Letter YF Liberia 2019

Decision Letter RV Liberia 2019

Decision Letter PENTA Liberia 2019

Decision Letter PCV Liberia 2019

Decision Letter HPV Liberia 2019

Decision letter Ebola Liberia 2015

Decision Letter NVS Liberia 2014(3)

Decision Letter Liberia IPV 2019

Date of Gavi approval: 18 September 2019

Decision letter NVS Liberia 2014 (2)

Decision Letter NVS Liberia 2017

Date of Gavi approval: 18 September 2019

Decision letter NVS Liberia 2014

Decision Letter NVS Liberia 2014(2)

Date of Gavi approval: 18 September 2019

Decision letter NVS Liberia 2013(2)

Decision letter HSS Liberia 2012

Date of Gavi approval: 18 September 2019

Partnership Framework Agreement Liberia

Decision Letter Liberia HSS 2019

Decision letter NVS Liberia 2013

Decision Letter Liberia ISD 2019

Decision Letter NVS Liberia 2018

Decision Letter NVS Liberia 2017 (3)

Decision Letter Devices Liberia 2017 (2)

Decision Letter NVS Liberia 2017 (2)

Decision Letter Devices Liberia 2017

Decision Letter CCEOP Liberia 2017

Decision Letter HSS Liberia 2017(2)

Decision Letter HSS Liberia 2017

HSS evaluation

The HSS evaluation team visited several countries (in depth country studies) and conducted a number of country desk reviews (Country desk studies).

HSS evaluation Liberia

COVAX Technical Assistance Plans

In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.

COVAX Technical Assistance Plan Liberia 2021

Targeted country assistance plans

Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.

Targeted Country Assistance Plan Liberia 2021

Targeted Country Assistance Plan Liberia 2020

Targeted Country Assistance Plan Liberia 2019

Targeted country assistance plan Liberia 2018

Targeted country assistance plan Liberia 2017

The joint appraisal report and Multi-Stakeholder Dialogue

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.

Multi-stakeholder dialogue Liberia 2020

Joint Appraisal Liberia 2019

Joint Appraisal Liberia 2018

Joint Appraisal Liberia 2017

Joint Appraisal Liberia 2015

Joint Appraisal Liberia 2014

Subscribe to our newsletter